- Home
- CHDN vs KYMR Comparison
CHDN vs KYMR Comparison
Compare CHDN & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CHDN | KYMR |
|---|---|---|
| Founded | 1928 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.9B | 6.6B |
| IPO Year | 1995 | 2020 |
Fundamental Metrics
Financial Performance| Metric | CHDN | KYMR |
|---|---|---|
| Price | $93.86 | $87.70 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 24 |
| Target Price | ★ $135.70 | $105.96 |
| AVG Volume (30 Days) | ★ 729.3K | 725.0K |
| Earning Date | 01-01-0001 | 04-03-2026 |
| Dividend Yield | ★ 0.47% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 5.49 | N/A |
| Revenue | ★ $1,809,800,000.00 | $47,072,000.00 |
| Revenue This Year | $8.80 | $19.43 |
| Revenue Next Year | $3.73 | N/A |
| P/E Ratio | $17.07 | ★ N/A |
| Revenue Growth | ★ 13.31 | N/A |
| 52 Week Low | $85.58 | $19.45 |
| 52 Week High | $119.11 | $103.00 |
Technical Indicators
Market Signals| Indicator | CHDN | KYMR |
|---|---|---|
| Relative Strength Index (RSI) | 42.22 | 68.85 |
| Support Level | $92.42 | $77.78 |
| Resistance Level | $98.90 | $103.00 |
| Average True Range (ATR) | 2.96 | 3.97 |
| MACD | 0.45 | 1.00 |
| Stochastic Oscillator | 61.31 | 86.86 |
Price Performance
Historical ComparisonAbout CHDN Churchill Downs Incorporated
Churchill Downs Inc is a gaming entertainment, online wagering, and racing company. It operates through three business segments: Live and Historical Racing, Wagering Services, and Gaming. The Live and Historical Racing segment includes live and historical pari-mutuel racing. The Wagering Services segment includes the revenue and expenses from pari-mutuel wagers through TwinSpires, companies retail and online sports betting business and Gaming segment includes revenue and expenses for the casino properties and associated racetracks that support the casino license. The Gaming segment generates revenue and expenses from slot machines, video lottery terminals, video poker, HRMs, ancillary food and beverage services, hotel services, commission on pari-mutuel wagering, and racing events.
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.